BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

699 related articles for article (PubMed ID: 17953858)

  • 1. [Antithrombotic therapy in ischemic stroke and transient ischemic attack].
    Overgaard K; Poulsen TS; Husted SE
    Ugeskr Laeger; 2007 Oct; 169(40):3379-82. PubMed ID: 17953858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adding aspirin to clopidogrel after TIA and ischemic stroke: benefits do not match risks.
    Hankey GJ; Eikelboom JW
    Neurology; 2005 Apr; 64(7):1117-21. PubMed ID: 15824331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Albers GW; Amarenco P; Easton JD; Sacco RL; Teal P
    Chest; 2008 Jun; 133(6 Suppl):630S-669S. PubMed ID: 18574275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack.
    Adams RJ; Albers G; Alberts MJ; Benavente O; Furie K; Goldstein LB; Gorelick P; Halperin J; Harbaugh R; Johnston SC; Katzan I; Kelly-Hayes M; Kenton EJ; Marks M; Sacco RL; Schwamm LH; ;
    Stroke; 2008 May; 39(5):1647-52. PubMed ID: 18322260
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
    Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in usage of alternative antiplatelet therapy after stroke and transient ischemic attack.
    Hills NK; Johnston SC
    Stroke; 2008 Apr; 39(4):1228-32. PubMed ID: 18323509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination antiplatelet agents for secondary prevention of ischemic stroke.
    Vande Griend JP; Saseen JJ
    Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary prevention of ischaemic stroke and TIA.
    Diener HC
    Cardiovasc J Afr; 2008; 19(4):229. PubMed ID: 18776974
    [No Abstract]   [Full Text] [Related]  

  • 9. [Secondary prevention with clopidogrel after TIA or stroke].
    Zuurbier SM; Vermeer SE; Hilkens PH; Algra A; Roos YB
    Ned Tijdschr Geneeskd; 2013; 157(25):A5836. PubMed ID: 23777963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke: PRoFESS subgroup analysis.
    Bath PM; Cotton D; Martin RH; Palesch Y; Yusuf S; Sacco R; Diener HC; Estol C; Roberts R;
    Stroke; 2010 Apr; 41(4):732-8. PubMed ID: 20181679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet therapy after noncardioembolic ischemic stroke or transient ischemic attack.
    Scalia L; Calderone D; Capodanno D
    Expert Rev Clin Pharmacol; 2022 Sep; 15(9):1027-1038. PubMed ID: 36031827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New opportunities to optimize antithrombotic therapy for secondary stroke prevention.
    Kim AS; Easton JD
    Int J Stroke; 2019 Apr; 14(3):220-222. PubMed ID: 30722755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
    Biller J
    J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary stroke prevention with antiplatelet therapy with emphasis on the cardiac patient: a neurologist's view.
    Gebel JM
    J Am Coll Cardiol; 2005 Sep; 46(5):752-5. PubMed ID: 16139120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights in antiplatelet therapy for patients with ischemic stroke.
    Chaturvedi S; Bhattacharya P
    Neurologist; 2011 Sep; 17(5):255-62. PubMed ID: 21881467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What's new in stroke? The top 10 studies of 2006-2008. Part I.
    Hart RG
    Pol Arch Med Wewn; 2008 Nov; 118(11):650-7. PubMed ID: 19140569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
    Lansberg MG; O'Donnell MJ; Khatri P; Lang ES; Nguyen-Huynh MN; Schwartz NE; Sonnenberg FA; Schulman S; Vandvik PO; Spencer FA; Alonso-Coello P; Guyatt GH; Akl EA
    Chest; 2012 Feb; 141(2 Suppl):e601S-e636S. PubMed ID: 22315273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Balancing Benefits and Risks of Long-Term Antiplatelet Therapy in Noncardioembolic Transient Ischemic Attack or Stroke.
    Hilkens NA; Algra A; Diener HC; Bath PM; Csiba L; Hacke W; Kappelle LJ; Koudstaal PJ; Leys D; Mas JL; Sacco RL; Greving JP
    Stroke; 2021 Oct; 52(10):3258-3265. PubMed ID: 34304604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?
    Diener HC
    Int J Stroke; 2006 Feb; 1(1):4-8. PubMed ID: 18706062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin and clopidogrel for prevention of ischemic stroke.
    Thomson RM; Anderson DC
    Curr Neurol Neurosci Rep; 2013 Feb; 13(2):327. PubMed ID: 23299823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.